Ravulizumab in Preemptive Living Donor Kidney Transplantation in Hereditary Atypical Hemolytic Uremic Syndrome

Detalles Bibliográficos
Autores principales: Schmidt, Tilman, Gödel, Markus, Mahmud, Maida, Fischer, Lutz, Huber, Tobias B., Kluger, Malte A., Grahammer, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806379/
https://www.ncbi.nlm.nih.gov/pubmed/35187213
http://dx.doi.org/10.1097/TXD.0000000000001289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806379/
https://www.ncbi.nlm.nih.gov/pubmed/35187213
http://dx.doi.org/10.1097/TXD.0000000000001289

Ejemplares similares